Living systematic review: 1. Introduction—the why, what, when, and how

…, J Meerpohl, H MacLehose, J Hilton, D Tovey… - Journal of clinical …, 2017 - Elsevier
Systematic reviews are difficult to keep up to date, but failure to do so leads to a decay in
review currency, accuracy, and utility. We are developing a novel approach to systematic …

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (Chinese edition)

…, KF Schulz, PG Shekelle, D Tovey… - Journal of …, 2009 - scholars.uthscsa.edu
… Altman, Doug Altman, Gerd Antes, David Atkins, Virginia Barbour, Nick Barrowman,
Jesse A. Berlin, Jocalyn Clark, Mike Clarke, Deborah Cook, Roberto D'Amico, Jonathan J …

The COVID-NMA project: building an evidence ecosystem for the COVID-19 pandemic

…, D Devane, G Rada, D Tovey… - Annals of internal …, 2020 - acpjournals.org
… Members of the COVID-NMA consortium who contributed to this work but did not author it:
Solaf Alawadhi 1,2 , Sihem Amer-Yahia 3 , Chiara Arienti 4 , David Auber 5 , Camila Ávila 6 …

[HTML][HTML] PRISMA for abstracts: reporting systematic reviews in journal and conference abstracts

…, I Chalmers, PC Gøtzsche, T Lasserson, D Tovey… - PLoS …, 2013 - journals.plos.org
Elaine Beller and colleagues from the PRISMA for Abstracts group provide a reporting
guidelines for reporting abstracts of systematic reviews in journals and at conferences.

Interleukin‐6 blocking agents for treating COVID‐19: a living systematic review

…, A Hróbjartsson, G Grasselli, D Tovey… - Cochrane database …, 2023 - cochranelibrary.com
Background It has been reported that people with COVID‐19 and pre‐existing autoantibodies
against type I interferons are likely to develop an inflammatory cytokine storm responsible …

[HTML][HTML] Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration

…, K Ranson, T TanTorres, P Tharyan, D Tovey… - Journal of Clinical …, 2016 - Elsevier
Background The promotion of health equity, the absence of avoidable and unfair differences
in health outcomes, is a global imperative. Systematic reviews are an important source of …

How to write a Cochrane systematic review

LK Henderson, JC Craig, NS Willis, D Tovey… - …, 2010 - Wiley Online Library
The Cochrane Collaboration is a global network whose aim is to improve health‐care decision
making through systematic reviews of the effects of health‐care interventions. Cochrane …

Enhancing the usability of systematic reviews by improving the consideration and description of interventions

…, JPA Ioannidis, D Moher, TJ Lasserson, DI Tovey… - Bmj, 2017 - bmj.com
The importance of adequate intervention descriptions in minimising research waste and
improving research usability and reproducibility has gained attention in the past few years. …

Efficacy and safety of COVID‐19 vaccines

…, M Davidson, C Riveros, D Tovey… - Cochrane Database …, 1996 - cochranelibrary.com
Background Different forms of vaccines have been developed to prevent the SARS‐CoV‐2
virus and subsequent COVID‐19 disease. Several are in widespread use globally. …

[PDF][PDF] Methodological standards for the conduct of new Cochrane Intervention Reviews

…, J Higgins, T Lasserson, D Tovey - Sl: Cochrane …, 2013 - sti.cochrane.org
Cochrane Reviews are seen as exemplifying best practice in the quality of both their conduct
and reporting. To maintain this position we need to improve and maintain the quality of our …